Galena BioPharma, Inc.Portland, OR United States
While there's no vaccine for breast cancer, Galena Biopharma has big plans for NeuVax, its drug candidate. NeuVax, which is in Phase III clinical trials, is being tested for its efficacy in reducing the recurrence of breast cancer in patients who can't take
|4640 Sw Macadam Ave Ste 270||Phone: +1-503-400-6610||http://www.galenabiopharma.com|
|Portland, OR 97239||Fax: -||Map This Company|
Galena BioPharma, Inc. Rankings
|Russell 2000 (June 2013)|
|10 executives listed for Galena BioPharma, Inc.'s Portland, OR location.|
|President, CEO, and Director||Mark Ahn|
|EVP and COO||Mark Schwartz|
|Company Type||Public - NASDAQ: GALE Headquarters|
Leverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Galena BioPharma, Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.